In Vitro Activities of Tigecycline against the Bacteroides fragilis Group

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 3, 2004, Pages 1034-1036

  Jacobus, N V ^a   McDermott, L A ^a   Ruthazer, R ^a   Snydman, D R ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOXITIN; CLINDAMYCIN; IMIPENEM; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS DISTASONIS; BACTERIUM ISOLATE; BACTEROIDES; BACTEROIDES FRAGILIS; BACTEROIDES OVATUS; BACTEROIDES THETAIOTAMICRON; BACTEROIDES UNIFORMIS; BACTEROIDES VULGATUS; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTEROIDES; BACTEROIDES FRAGILIS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 1442324637     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.3.1034-1036.2004     Document Type: Article

References (13)

1. Aldridge, K. E., D. Ashcraft, K. Cambre, C. L. Pierson, S. G. Jenkins, and J. E. Rosenblatt. 2001. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group Prevotella, Fusobacterium, Prophyromonas, and Peptostreptococcus species. Antimicrob. Agents Chemother. 45:1238-1243.
2. Betriu, C., I. Rodriguez-Avial, B. A. Sánchez, M. Gomez, J. Álvarez, J. J. Picazo, and Spanish Group of Tigecycline. 2002. In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain. Antimicrob. Agents Chemother. 46:892-895.
3. Edlund C., and C. E. Nord. 2000. In vitro susceptibility of anaerobic bacteria to GAR-936, a new glycylcycline. Clin. Microbiol. Infect. 6:158-163.
4. Gales, A. C., and R. N. Jones. 2000. Antimicrobial activity and spectrum of the new glycylcycline GAR-936 tested against 1,203 recent clinical bacterial isolates. Diagn. Microbiol. Infect. Dis. 36:19-36.
5. Holdeman, L. V., and W. E. C. Moore. 1977. Anaerobic laboratory manual, 4th ed. Virginia Polytechnic Institute and State University. Blacksburg, Va.
6. National Committee for Clinical Laboratory Standards. 1997. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard. NCCLS document M11-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
7. Petersen, P. J., N. V. Jacobus, W. J. Weiss, P. E. Sum, and R. T. Testa. 1999. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob. Agents Chemother. 43:738-744.
8. Petersen, P. J., P. A. Bradford, W. J. Weiss, T. M. Murphy, P. E. Sum, and S. J. Projan. 2002. In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens. Antimicrob. Agents Chemother. 46:2595-2601.
9. Snydman D. R., L. McDermott, G. J. Cuchural, D. W. Hecht, P. B. Iannini, L. J. Harrell, S. G. Jenkins, J. P. O'Keefe, C. L. Pierson, J. D. Rihs, V. L. Yu, S. M. Finegold, and S. L. Gorbach. 1996. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Clin. Infect. Dis. 23:(Suppl. 1):S54-S65.
10. Snydman, D. R., N. V. Jacobus, L. A. McDermott, and S. E. Supran. 2000. Comparative in vitro activities of clinafloxacin and trovafloxacin against 1, 000 isolates of Bacteroides fragilis group: effect of the medium on test results. Antimicrob. Agents Chemother. 44:1710-1712.
11. Snydman, D. R., N. V. Jacobus, L. A. McDermott, R. Ruthazer, E. Goldstein, S. M. Finegold, L. J. Harrell, D. W. Hecht, S. Jenkins, C. Pierson, R. Venezia, J. Rihs, and S. L. Gorbach. 2002. In vitro activities of newer quinolones against Bacteroides group organisms. Antimicrob. Agents Chemother. 46:3276-3279.
12. Summanem P., E. J. Baron, D. M. Citron, C. A. Strong, H. Wexler, and S. M. Finegold. 1993. Wadsworth anaerobic bacteriology manual, 5th ed. Star Publishing Co., Belmont, Calif.
13. Testa, R. T., P. J. Petersen, N. V. Jacobus, P. E. Sum, V. J. Lee, and F. P. Tally. 1993. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Amimicrob. Agents Chemother. 37:2270-2277.